- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BMRN
Recent news which mentions BMRN
If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names
January 10, 2024
From InvestorPlace
4 Preeminent Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
December 02, 2023
From Motley Fool
Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures
November 09, 2023
From InvestorPlace
3 Promising Biotech Stocks Flying Under the Radar
November 08, 2023
From InvestorPlace
Tickers
BMRN
From InvestorPlace
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
November 07, 2023
From Benzinga
4 Unique Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
November 04, 2023
From Motley Fool
Why Is Gene Therapy Player PTC Therapeutics Stock Plunging Today?
October 27, 2023
From Benzinga
3 Under-the-Radar Biotech Stocks to Buy in 2023
October 19, 2023
From Motley Fool
15 Analysts Have This to Say About Biomarin Pharmaceutical
October 16, 2023
Tickers
BMRN
From Benzinga
Impact on BioMarin's Sentiment: Voxzogo's Triumph Clouded by Uncertainty
September 28, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
September 28, 2023
From Benzinga
4 Awe-Inspiring Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
September 23, 2023
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023
September 18, 2023
From Benzinga
Investors should stick to the ‘late cycle playbook’ and buy these sectors, says Morgan Stanley’s Mike Wilson
September 18, 2023
From MarketWatch
10 Health Care Stocks Whale Activity In Today's Session
September 15, 2023
From Benzinga
What 16 Analyst Ratings Have To Say About Biomarin Pharmaceutical
September 13, 2023
Tickers
BMRN
From Benzinga
4 Preeminent Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
September 02, 2023
From Motley Fool
4 Unforgettable Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
August 12, 2023
From Motley Fool
Biomarin's Q2 Beat Street View, Raises Voxzogo Annual Guidance Driven By Global Demand
August 01, 2023
Tickers
BMRN
From Benzinga
Earnings Scheduled For July 31, 2023
July 31, 2023
From Benzinga
From Benzinga
From InvestorPlace
BioMarin Presents ~20% Upside Amid Voxzogo's Success and Slow Roctavian Uptake, Analyst Says
July 05, 2023
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.